NASDAQ
Immix Biopharma, Inc. (IMMX) has a current ratio of 10.01x as of Monday, May 25, 2026. This represents a 63.37% decrease compared to its 12-month average of 27.34x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.